Needle Biopsy Market Is Ready To Grow Globally With Phenomenal Trend Diversity Between To 2022-2030

High Focus on Improving Visibility of Biopsy Needles to Aid Market Growth

In the past decade, improved awareness and knowledge of cancers coupled with longer life expectancy has played a key role in augmenting the demand for needle biopsies. Advancements in cancer diagnosis and major developments in the medical sector have primarily contributed to the increasing adoption of biopsy needles due to which, the needle biopsy market is projected to witness steady growth during the forecast period. Furthermore, increasing demand for biopsy needles with improved visibility in image guidance procedures, including ultrasound, is expected to propel the demand for biopsy needles.

Get the sample copy of report@ https://qyresearchmedical.com/sample/111603

The demand for biopsy needles is on the rise due to improved visibility and positional accuracy– a factor that is likely to propel the global biopsy needles market during the forecast period. A large number of players involved in the needle biopsy market are increasingly focusing on launching innovative biopsy needles with high visibility. In addition, market players are increasingly focusing on minimizing the deflection of needles in needle biopsy procedures. The increasing demand for interventional medical procedures around the world is anticipated to provide lucrative opportunities for players involved in the current needle biopsy market during the forecast period.

At the back of these factors, along with increasing demand for minimally invasive and accurate biopsies, the global needle biopsy market is projected to cross a market value of US$ 1.2 Bn by the end of 2030.

Surge in Number of Cancer Cases Worldwide to Drive Market

The needle biopsy procedure is primarily deployed to diagnose prostate, skin, and breast cancer. Over the past couple of decades, the exponential rise in the number of cancer patients around the world is one of the primary factors due to which, the demand for needle biopsy has witnessed impressive growth. Moreover, the increasing demand for minimally invasive needle biopsy procedures is another major factor anticipated to augment the demand for needle biopsy during the forecast period. A notable surge in the number of breast cancer patients is expected to provide a massive boost to the adoption of needle biopsy procedures. This is another factor that is likely to provide considerable boost to the overall growth of the needle biopsy market during the forecast period.

Furthermore, the growing need to detect early signs of a preventable disease to improve survival rates of patients is another factor due to which, the demand for needle biopsy is on the rise.

Market players are increasingly focusing on research and development activities and other innovative techniques to improve the overall success rate of needle biopsy procedures. For instance, a new type of needle biopsy is currently being developed by a team of researchers as part of the Aalto University project– AdvaNeedle. The research primarily aims to address drawbacks of the current thick-and-fine-needle samples by minimizing pain and inadequate diagnosis.

Demand to Remain Steady During COVID-19 Pandemic

The COVID-19 pandemic has derailed the growth of several core industries as a result of stringent lockdowns and restrictions on transportation and trade. However, the medical sector is likely to largely remain unaffected due to the COVID-19 crisis, as manufacturing of medical devices, drugs, and medication are classified as ‘essential goods and services’. The demand for needle biopsy procedures has remained steady throughout 2020. Thus, the needle biopsy market is expected to exhibit a steady growth. Although the number of non-critical procedures has witnessed significant decline, the demand for minimally invasive needle biopsy procedures is expected to provide considerable boost to the overall prospects of the needle biopsy market in 2020.

View full report@ https://qyresearchmedical.com/report/needle-biopsy-market-type-fine-needle-aspiration-biopsy-and-core-needle-biopsy-application-breast-cancer-thyroid-cancer-prostate-cancer-liver-cancer-and-others-and-end-user-hospital-diagnostics-imaging-2020-2030/111603

Analysts’ Viewpoint

The global needle biopsy market is expected to expand at a healthy CAGR of 7% during the forecast period. The market growth can be attributed to increasing prevalence of cancer worldwide, research and development activities, technological advancements, and high demand for minimally invasive needle biopsy procedures. Market players should focus on improving various physical and functional parameters of biopsy needles to gain a competitive edge in the current market landscape.

Needle Biopsy Market: Overview

The global needle biopsy market for the historical period 2018–2019 and forecast period 2020–2030, increase in incidence of cancer across the globe, rise in global geriatric population, and government initiatives to spread awareness about cancer are expected to drive the global market during the forecast period

According to the report, the needle biopsy market was valued at ~US$ 630 Mn in 2019. It is anticipated to expand at a CAGR of 7% from 2020 to 2030. In terms of volume, around 19,351,640 biopsy needles were used in 2019, and the number is projected to reach at 33,683,957 by the end of 2030.

Increase in Incidence of Cancer Worldwide: Key Drivers

High prevalence and rise in incidence rate of cancer across the globe are likely to propel the market during the forecast period

Cancer is the second-leading cause of death worldwide. In 2018, around 9.6 million deaths were estimated to have occurred globally due to cancer. Of every six deaths globally, around one death is due to cancer.

According to WHO, globally, around 782,000 deaths were caused due to liver cancer in 2018. It is the sixth-most commonly occurring cancer worldwide.

Moreover, according to the World Cancer Research Fund, in 2018, globally, around 567,233 cases of thyroid cancer were reported, accounting for 3.3% of all cancer cases

Increase in Geriatric Population to Boost Market

Rapidly ageing population that are more prone to chronic medical conditions, especially cancer, is estimated to drive the market during the forecast period

According to the World Health Organization, the geriatric population (people aged above 60) is expected to double by 2050, from 962 million in 2017 to 2 billion in 2050. Globally, the geriatric population is increasing at a rapid pace as compared to that of the young population.

Purchase Complete Report Now@ https://qyresearchmedical.com/report/checkout/111603/2900

The geriatric population is more susceptible to various cancers, especially breast cancer and prostate cancer

Breast cancer commonly occurs in women of over 40 years. According to a recent article published by the National Cancer Institute, U.S., reviewed on September, 2012, 12.4% women born in the U.S. are likely to develop breast cancer in their lifetime, i.e., one among eight women would be diagnosed with breast cancer.

According to the American Society of Clinical Oncology (ASCO), more than 80% of prostate cancer cases are diagnosed in people who are aged 65 years and older

Thus, rapid increase in the geriatric population across the globe is a prominent factor that is expected to boost the needle biopsy market during the forecast period

Availability of Alternative Biopsies for Disease Diagnosis to Hamper Market

Liquid biopsy procedure holds significant potential for the diagnosis of a wide range of diseases and cancer. The method is a minimally invasive procedure and easy to perform compared to conventional needle biopsy.

Presently, R&D on cancer diagnosis is primarily focused on liquid biopsy. Market players and research institutes are conducting extensive clinical trials to develop highly sensitive biopsy platforms.

In May 2018, Grail, a U.S.-based biotechnology company, raised US$ 1 Bn in VC funding and embarked on a 120,000-patient study for early breast cancer detection

In January 2018, researchers at Johns Hopkins developed a test called CancerSEEK, which is a non-invasive multianalyte test that analyzes levels of eight cancer proteins and presence of cancer gene mutation in circulating DNA in blood. The test included more than 1,000 patients with non-metastatic, stages I to III cancers of the ovary, stomach, liver, pancreas, esophagus, lungs, colorectum, and breast.

Thus, extensive research on liquid biopsy aimed at promoting early and non-invasive diagnosis in cancer is likely to restrain the needle biopsy market during the forecast period

Needle Biopsy Market: Competition Landscape

This report profiles major players in the global needle biopsy market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments

The global needle biopsy market is highly consolidated, with few players holding majority of market share in global market

Leading players operating in the global needle biopsy market include

  • Becton
  • Dickinson and Company
  • Merit Medical Systems, Inc.
  • Argon Medical and Olympus Corporation
  • INRAD, Inc.
  • Argon Medical
  • CONMED Corporation
  • Stryker Corporation
  • Medtronic plc

Needle Biopsy Market: Key Developments

Key players in the global needle biopsy market are engaged in regulatory approvals, launch of new products, and acquisition & collaborative agreements with other companies. These strategies are likely to fuel the global needle biopsy market. A few expansion strategies adopted by players operating in the global needle biopsy market are:

In May 2019, Argon Medical acquired Mana-Tech, Ltd., its exclusive distributor for the U.K. and Ireland. This acquisition strengthened the company’s distribution network in Europe.

In August 2017, Hologic, Inc. launched the Brevera breast biopsy system with CorLumina imaging technology in the U.S. The biopsy system is designed to increase biopsy accuracy with real-time imaging to provide valuable information at point of care.

In November 2017, Merit Medical Systems, Inc. entered into a definitive agreement to acquire Becton Dickinson and Company’s soft tissue core needle biopsy product line and Aspira product line of tunneled home drainage catheters and accessories. The total agreement was worth US$ 100 Mn.

The report on the global needle biopsy market discussed individual strategies, followed by company profiles of manufacturers of needle biopsy. The competition landscape section has been included in the report to provide readers with a dashboard view of key players operating in the global needle biopsy market.

Key Questions Answered in Needle Biopsy Market Report

  • What is the sales/revenue generated by the global needle biopsy market across all the regions during the forecast period?
  • What is the volume of biopsy needles across all the regions during the forecast period?
  • What are the key trends in the global needle biopsy market?
  • What are the major drivers, restraints, and opportunities in the global market?
  • Which region is set to expand at the fastest CAGR during the forecast period?
  • Which segment will have the highest revenue globally in 2030 and which biopsy needle will expand at the fastest CAGR during the forecast period?

Needle Biopsy Market – Segmentation

Type

  • Fine-needle Aspiration Biopsy
  • Core Needle Biopsy

Application

  • Breast Cancer
  • Thyroid Cancer
  • Prostate Cancer
  • Transperineal
  • Transrectal
  • Liver Cancer
  • Other

End User

  • Hospital
  • Diagnostics & Imaging Centers
  • Research Laboratories & Academic Institutes
  • Others

Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

TABLE OF CONTENT

1. Preface

1.1. Market  Definition and Scope

1.2. Market  Segmentation

1.3. Key Research Objectives

1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Needle Biopsy Market

4. Market  Overview

4.1. Introduction

4.1.1. Market  Definition

4.1.2. Industry Evolution / Developments

4.2. Overview

4.3. Market  Dynamics

4.3.1. Drivers

4.3.2. Restraints

4.3.3. Opportunities

4.4. Global Needle Biopsy Market Analysis and Forecast, 2018–2030

4.4.1. Market  Revenue Projections (US$ Mn)

4.4.2. Market Volume/Unit Shipments Projections

5. Key Insights

5.1. Disease Prevalence & Incidence Rate globally with key countries

5.2. Overview of the Image Guided Needle Biopsy

5.3. Regulatory Scenario by Region/globally

5.4. COVID-19 Pandemics Impact on Global Needle Biopsy Market

6. Global Needle Biopsy Market Analysis and Forecast, by Type

6.1. Introduction & Definition

6.2. Key Findings / Developments

6.3. Needle Biopsy Market Value & Volume Forecast, by Type, 2018–2030

6.3.1. Fine-Needle Aspiration Biopsy

6.3.2. Core Needle Biopsy

6.4. Market Attractiveness Analysis, by Type

7.   Global Needle Biopsy Market Analysis and Forecast, by Application

7.1. Introduction & Definition

7.2. Key Findings / Developments

7.3. Needle Biopsy Market Value Forecast, by Application, 2018–2030

7.3.1. Breast Cancer

7.3.2. Thyroid Cancer

7.3.3. Prostate Cancer

7.3.3.1. Transperineal

7.3.3.2. Transrectal

7.3.4. Liver Cancer

7.3.5. Others

7.4. Market  Attractiveness Analysis, by Application

8. Global Needle Biopsy Market Analysis and Forecast, by End-user

8.1. Introduction & Definition

8.2. Key Findings / Developments

8.3. Needle Biopsy Market Value Forecast, by End-user, 2018–2030

8.3.1. Hospitals

8.3.2. Diagnostics and Imaging Centers

8.3.3. Research Laboratories and Academic Institutes

8.3.4. Others

8.4. Market  Attractiveness Analysis, by End-user

9. Global Needle Biopsy Market Analysis and Forecast, by Region

……

Purchase Complete Report Now@ https://qyresearchmedical.com/report/checkout/111603/2900

You can place an order or ask any questions, please feel free to contact sales@qyresearchmedical.com | +1 9197 992 333

About Us

QYResearch Medical, focuses on custom research, management consulting, IPO consulting, industry chain research, and data base & seminar services. The company owns large basic databases (such as National Bureau of Statistics Database, Customs Import and Export Database, Industry Association Database, etc.), expert resources (including industry experts who own more than 10 years experiences on marketing or R&D in industries of healthcare services, medical technology & devices, etc.), professional survey team (the team members obtained more than 3 years market survey experience and more than 2 years deep expert interview experience), and excellent data analysis team (SPSS statistics and PPT graphics process team).

QYResearch Medical has more than 4000 global well-known customers, covering more than 30 industries including pharmaceuticals, medical technology & devices, healthcare services etc. Company services cover one-stop solution as Data-Analysis-Suggestion-Consulting Implementation. Research regions cover China, US, EU, Asia, Middle East and Africa, South America, Australia, and other regions in the world.

For Latest Update Follow Us:

https://www.linkedin.com/company/qyresearch-medical/

https://www.facebook.com/QYResearch-Medical-108186514228917/

https://twitter.com/qyresearchmedi